Back

Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Paula Rodriguez Montes

University Hospital Getafe, Madrid (Spain)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Tezuka (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor M. Mckittrick (Limerick, IE)
Abstract Slides Video
Presentation thumbnail
Doctor C. Neerapattanakul (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Doctor T. Nishikimi (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Real-world monocentric experience of early impact of SGLT2 inhibitors on NT-proBNP levels in heart failure
thumbnail
Congress Presentation
The prognostic role of regular NT-proBNP measurement after a rapid-up titration programme of guideline-directed medical therapy in heart failure: essential or superfluous?
thumbnail
Congress Presentation
Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources